Cord Blood Therapies
克利夫科德 (HPC 脐带血)
CLEVELAND CORD BLOOD CENTER
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC 脐带血
BLOODWORKS
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC 脐带血
MD ANDERSON CORD BLOOD BANK
Approved by the U.S. FDA in June 2018 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
Hemacord (HPC 脐带血)
NEW YORK BLOOD CENTER
Approved by the U.S. FDA in 2011 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
Allocord (HPC 脐带血)
SSM CARDINAL GLENNON CHILDREN’S MEDICAL CENTER
Approved by the U.S. FDA in 2013 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
杜科德 (HPC 脐带血)
DUKE UNIVERSITY MEDICAL CENTER
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC 脐带血
CLINIMMUNE
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC 脐带血
LIFE SOUTH
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
